240 related articles for article (PubMed ID: 20207279)
21. Successful treatment of vertebral osteomyelitis with linezolid in a patient receiving hemodialysis and with persistent methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus bacteremias.
Melzer M; Goldsmith D; Gransden W
Clin Infect Dis; 2000 Jul; 31(1):208-9. PubMed ID: 10913433
[No Abstract] [Full Text] [Related]
22. Ineffectiveness of daptomycin in the treatment of septic pulmonary emboli and persistent bacteremia caused by methicillin-resistant Staphylococcus aureus.
Hagiya H; Hagioka S; Otsuka F
Intern Med; 2013; 52(22):2577-82. PubMed ID: 24240800
[TBL] [Abstract][Full Text] [Related]
23. Linezolid resistance in three isolates of coagulase-negative staphylococci.
Cieloszyk K; Amodio-Groton M; Saeed M; Coyle CM
Ann Pharmacother; 2007 Mar; 41(3):526-7. PubMed ID: 17341527
[No Abstract] [Full Text] [Related]
24. Evaluation of the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
Usery JB; Vo NH; Finch CK; Cleveland KO; Gelfand MS; Self TH
Am J Med Sci; 2015 Jan; 349(1):36-41. PubMed ID: 25233042
[TBL] [Abstract][Full Text] [Related]
25. Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus.
Bennett JW; Murray CK; Holmes RL; Patterson JE; Jorgensen JH
Diagn Microbiol Infect Dis; 2008 Apr; 60(4):437-40. PubMed ID: 18096352
[TBL] [Abstract][Full Text] [Related]
26. Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
Marty FM; Yeh WW; Wennersten CB; Venkataraman L; Albano E; Alyea EP; Gold HS; Baden LR; Pillai SK
J Clin Microbiol; 2006 Feb; 44(2):595-7. PubMed ID: 16455920
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of linezolid-based salvage therapy compared with glycopeptide-based therapy in patients with persistent methicillin-resistant Staphylococcus aureus bacteremia.
Park HJ; Kim SH; Kim MJ; Lee YM; Park SY; Moon SM; Park KH; Chong YP; Lee SO; Choi SH; Woo JH; Kim YS
J Infect; 2012 Dec; 65(6):505-12. PubMed ID: 22902942
[TBL] [Abstract][Full Text] [Related]
28. Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus.
Nannini E; Murray BE; Arias CA
Curr Opin Pharmacol; 2010 Oct; 10(5):516-21. PubMed ID: 20598637
[TBL] [Abstract][Full Text] [Related]
29. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
[TBL] [Abstract][Full Text] [Related]
30. Successful treatment of methicillin-resistant Staphylococcus aureus mitral valve endocarditis with sequential linezolid and telavancin monotherapy following daptomycin failure.
Joson J; Grover C; Downer C; Pujar T; Heidari A
J Antimicrob Chemother; 2011 Sep; 66(9):2186-8. PubMed ID: 21653600
[No Abstract] [Full Text] [Related]
31. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
Stein GE; Wells EM
Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750
[TBL] [Abstract][Full Text] [Related]
32. Resistance to linezolid in a methicillin-susceptible Staphylococcus aureus clinical isolate without previous exposure to oxazolidinones.
Quiles-Melero I; García-Perea A; de Pablos M; Gómez-Gil R; Mingorance J
Int J Med Microbiol; 2012 Jul; 302(3):145-7. PubMed ID: 22578666
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of daptomycin in complicated skin and skin-structure infections due to methicillin-sensitive and -resistant Staphylococcus aureus: results from the CORE Registry.
Martone WJ; Lamp KC
Curr Med Res Opin; 2006 Dec; 22(12):2337-43. PubMed ID: 17257448
[TBL] [Abstract][Full Text] [Related]
34. Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies.
Shorr AF; Kunkel MJ; Kollef M
J Antimicrob Chemother; 2005 Nov; 56(5):923-9. PubMed ID: 16195255
[TBL] [Abstract][Full Text] [Related]
35. Emergence of linezolid resistance in a methicillin resistant Staphylococcus aureus strain.
Hentschke M; Saager B; Horstkotte MA; Scherpe S; Wolters M; Kabisch H; Grosse R; Heisig P; Aepfelbacher M; Rohde H
Infection; 2008 Feb; 36(1):85-7. PubMed ID: 18165857
[No Abstract] [Full Text] [Related]
36. Linezolid use in sepsis due to methicillin-susceptible Staphylococcus aureus.
De Gascun C; Rajan L; O'Neill E; Smyth EG
J Antimicrob Chemother; 2006 Jan; 57(1):150-1. PubMed ID: 16244085
[No Abstract] [Full Text] [Related]
37. Endocarditis caused by methicillin-resistant Staphylococcus aureus: treatment failure with linezolid.
Ruiz ME; Guerrero IC; Tuazon CU
Clin Infect Dis; 2002 Oct; 35(8):1018-20. PubMed ID: 12355391
[TBL] [Abstract][Full Text] [Related]
38. Management of serious meticillin-resistant Staphylococcus aureus infections: what are the limits?
Gould IM; Cauda R; Esposito S; Gudiol F; Mazzei T; Garau J
Int J Antimicrob Agents; 2011 Mar; 37(3):202-9. PubMed ID: 21300528
[TBL] [Abstract][Full Text] [Related]
39. Linezolid therapy of bloodborne teicoplanin-resistant Staphylococcus haemolyticus.
Mohammedi I; Malhière S; Robert D; Charveriat MA; Etienne J
Infection; 2006 Oct; 34(5):292-3. PubMed ID: 17033757
[No Abstract] [Full Text] [Related]
40. Activity of daptomycin and selected antimicrobial agents tested against Staphylococcus aureus from patients with bloodstream infections hospitalized in European medical centers.
Sader HS; Watters AA; Fritsche TR; Jones RN
J Chemother; 2008 Feb; 20(1):28-32. PubMed ID: 18343740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
